Gesualdi, L.; Berardini, M.; Scicchitano, B.M.; Castaldo, C.; Bizzarri, M.; Filippini, A.; Riccioli, A.; Schiraldi, C.; Ferranti, F.; Liguoro, D.;
et al. ERK Signaling Pathway Is Constitutively Active in NT2D1 Non-Seminoma Cells and Its Inhibition Impairs Basal and HGF-Activated Cell Proliferation. Biomedicines 2023, 11, 1894.
https://doi.org/10.3390/biomedicines11071894
AMA Style
Gesualdi L, Berardini M, Scicchitano BM, Castaldo C, Bizzarri M, Filippini A, Riccioli A, Schiraldi C, Ferranti F, Liguoro D,
et al. ERK Signaling Pathway Is Constitutively Active in NT2D1 Non-Seminoma Cells and Its Inhibition Impairs Basal and HGF-Activated Cell Proliferation. Biomedicines. 2023; 11(7):1894.
https://doi.org/10.3390/biomedicines11071894
Chicago/Turabian Style
Gesualdi, Luisa, Marika Berardini, Bianca Maria Scicchitano, Clotilde Castaldo, Mariano Bizzarri, Antonio Filippini, Anna Riccioli, Chiara Schiraldi, Francesca Ferranti, Domenico Liguoro,
and et al. 2023. "ERK Signaling Pathway Is Constitutively Active in NT2D1 Non-Seminoma Cells and Its Inhibition Impairs Basal and HGF-Activated Cell Proliferation" Biomedicines 11, no. 7: 1894.
https://doi.org/10.3390/biomedicines11071894
APA Style
Gesualdi, L., Berardini, M., Scicchitano, B. M., Castaldo, C., Bizzarri, M., Filippini, A., Riccioli, A., Schiraldi, C., Ferranti, F., Liguoro, D., Mancini, R., Ricci, G., & Catizone, A.
(2023). ERK Signaling Pathway Is Constitutively Active in NT2D1 Non-Seminoma Cells and Its Inhibition Impairs Basal and HGF-Activated Cell Proliferation. Biomedicines, 11(7), 1894.
https://doi.org/10.3390/biomedicines11071894